The S100A8 plasma levels were found to be increased in MPN patients [32], whereas our study specifically revealed that S100A8 was more pronouncedly overexpressed in CALRDEL-mutated cases. This evidence concerns the gene S100A8 and myeloproliferative neoplasm.